Biomarkers could tailor preventative or therapeutic aspirin regimens by predicting patients’ response.
The Division of Neurosurgery will become the Department on Oct. 1, 2013, elevating the profile of an already world-renowned program.
In this preliminary analysis, the first human study treatment neither built up in organs nor destroyed the bone marrow’s ability to make blood cells.
Partridge, director of the UAB Comprehensive Cancer Center, was honored by the American Cancer Society for his exceptional talents and his commitment to make progress towards finishing the fight against cancer.
In an engineering feat, the UAB Comprehensive Cancer Center installs a cyclotron unique to academic medical settings.